MMP-12 has previously been associated with blood-brain barrier disruption via tight junction protein degradation after focal cerebral ischemia (Chelluboina et al., 2015), while MMP-19 was associated with gliomas (Luo et al., 2018), but no studies had associated them with PNN formation or degradation. This evidence concerns the gene MMP19 and central nervous system cancer.